Cardlytics, Inc. (NASDAQ:CDLX) Receives $5.20 Consensus Price Target from Brokerages

Cardlytics, Inc. (NASDAQ:CDLX) has received a consensus rating of “Hold” from the seven ratings firms that are covering the stock, MarketBeat Ratings reports. One research analyst has rated the stock with a sell rating, five have given a hold rating and one has issued a strong buy rating on the company. The average 12-month price objective among brokers that have issued ratings on the stock in the last year is $5.20.

Several research firms recently commented on CDLX. Needham & Company LLC reiterated a “hold” rating on shares of Cardlytics in a research report on Thursday, March 13th. Lake Street Capital reduced their price target on shares of Cardlytics from $3.00 to $2.50 and set a “hold” rating for the company in a research report on Thursday, May 8th. Finally, Evercore ISI reduced their price target on shares of Cardlytics from $4.00 to $3.00 and set an “in-line” rating for the company in a research report on Thursday, March 13th.

Cardlytics Stock Up 12.1%

Shares of NASDAQ:CDLX opened at $2.17 on Friday. The firm has a 50 day simple moving average of $1.81 and a 200-day simple moving average of $2.95. Cardlytics has a twelve month low of $1.22 and a twelve month high of $10.01. The company has a market capitalization of $113.93 million, a PE ratio of -0.36 and a beta of 1.30. The company has a current ratio of 1.18, a quick ratio of 1.18 and a debt-to-equity ratio of 2.40.

Insider Transactions at Cardlytics

In related news, CFO Alexis Desieno sold 24,778 shares of the firm’s stock in a transaction that occurred on Tuesday, February 18th. The shares were sold at an average price of $3.40, for a total value of $84,245.20. Following the transaction, the chief financial officer now owns 140,948 shares in the company, valued at approximately $479,223.20. This trade represents a 14.95% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Amit Gupta sold 46,857 shares of the firm’s stock in a transaction that occurred on Tuesday, February 18th. The shares were sold at an average price of $3.40, for a total transaction of $159,313.80. Following the completion of the transaction, the chief executive officer now owns 418,637 shares in the company, valued at $1,423,365.80. The trade was a 10.07% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 71,938 shares of company stock worth $244,017 in the last three months. Company insiders own 4.40% of the company’s stock.

Institutional Trading of Cardlytics

A number of hedge funds have recently made changes to their positions in CDLX. Barclays PLC raised its stake in shares of Cardlytics by 223.9% during the third quarter. Barclays PLC now owns 58,026 shares of the company’s stock valued at $186,000 after purchasing an additional 40,112 shares during the period. Tallon Kerry Patrick purchased a new stake in shares of Cardlytics during the fourth quarter valued at approximately $37,000. SG Americas Securities LLC raised its stake in shares of Cardlytics by 38.2% during the fourth quarter. SG Americas Securities LLC now owns 19,490 shares of the company’s stock valued at $72,000 after purchasing an additional 5,392 shares during the period. Check Capital Management Inc. CA raised its stake in shares of Cardlytics by 11.0% during the fourth quarter. Check Capital Management Inc. CA now owns 56,200 shares of the company’s stock valued at $209,000 after purchasing an additional 5,550 shares during the period. Finally, Global Retirement Partners LLC raised its stake in shares of Cardlytics by 54.7% during the fourth quarter. Global Retirement Partners LLC now owns 19,800 shares of the company’s stock valued at $73,000 after purchasing an additional 7,000 shares during the period. Hedge funds and other institutional investors own 68.10% of the company’s stock.

About Cardlytics

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.